Method Article

Murine Endoscopy for In Vivo Multimodal Imaging of Carcinogenesis and Assessment of Intestinal Wound Healing and Inflammation

18.8K views

DOI:

10.3791/51875

August 26th, 2014

* These authors contributed equally

In This Article

Summary

Small animal imaging techniques allow serial diagnostic examinations and therapeutic interventions in vivo. Recently, the scope of applications has significantly widened and currently includes assessment of colonic tumor development, wound healing and monitoring of inflammation. This protocol illustrates these diverse potential applications of murine endoscopy.

Abstract

Mouse models are widely used to study pathogenesis of human diseases and to evaluate diagnostic procedures as well as therapeutic interventions preclinically. However, valid assessment of pathological alterations often requires histological analysis, and when performed ex vivo, necessitates death of the animal. Therefore in conventional experimental settings, intra-individual follow-up examinations are rarely possible. Thus, development of murine endoscopy in live mice enables investigators for the first time to both directly visualize the gastrointestinal mucosa and also repeat the procedure to monitor for alterations. Numerous applications for in vivo murine endoscopy exist, including studying intestinal inflammation or wound healing, obtaining mucosal biopsies repeatedly, and to locally administer diagnostic or therapeutic agents using miniature injection catheters. Most recently, molecular imaging has extended diagnostic imaging modalities allowing specific detection of distinct target molecules using specific photoprobes. In conclusion, murine endoscopy has emerged as a novel cutting-edge technology for diagnostic experimental in vivo imaging and may significantly impact on preclinical research in various fields.

Introduction

Animal models have greatly enriched our understanding of numerous intestinal pathologies. The laboratory mouse (Mus musculus) has emerged as a prime animal model in biomedical research due to its abundant genetic and genomic information and is readily available in transgenic and knockout strains. In addition to enhancing understanding disease pathogenesis, animal models are also importantly used for testing drug candidates as well as preclinical diagnostic or therapeutic interventions. However, despite the variety of mouse models mimicking human disease, many diagnostic and interventional options that are routinely used in patient care are not available for mice. Accordingly, surveillance strategies to monitor the course of murine disease or the effect of therapeutic interventions are often limited to indirect observations or post mortem analyses. While non-invasive procedures exist for monitoring mice vitality like disease activity indices, quantification of weight loss or gain, blood, urine and feces analyses, these are only indirect indicators and are biased by inter-individual variability. Additionally, post mortem analyses prevent longitudinal observations at repetitive time points. Sophisticated imaging techniques to monitor disease activity in mice have only recently been introduced 1,2. Although these imaging techniques allow for repetitive analyses, they only provide a descriptive and often imprecise view on the gut, do not enable direct mucosal visualization or allow diagnostic or therapeutic interventions such as biopsy acquisition or topical and intramucosal application of drug candidates.

Recently, high-resolution endoscopic systems for use in live mice have been developed 3,4. For the first time these endoscopic techniques allow direct visualization of endoluminal colonic disease pathologies such as wound healing or intestinal inflammation providing objective, real-time status allowing longitudinal studies in the same animal at repetitive time points. Aside from allowing repeated biopsies in an individual mouse, endoscopic systems can also be used to therapeutically influence a distinct tumor or localized inflammation by allowing direct application of a substance to the area of interest. Furthermore, as therapeutic and control substances can be delivered directly to the area of interest, this can be performed in the same mouse, excluding inter-individual variability. These systems have now been employed for the assessment of colonic inflammation, wound healing, laparoscopic liver biopsies and orthotopic induction of liver tumors 8 and tumor development using various scoring systems such as the murine endoscopic index of colitis severity (MEICS) 5-7. MEICS consists of five parameters to assess inflammation: thickening of the colon wall, changes of the vascular pattern, presence of fibrin, granularity of the mucosal surface, and stool consistence.

In this protocol we describe the use of rigid endoscopy in murine models of intestinal wound healing, inflammation and colon cancer. First, we demonstrate the endoscopic evaluation of wound healing and colonic inflammation as well as longitudinal assessment of colitis activity and the study of cancerogenesis in the murine colon. Beyond the descriptive use of murine endoscopy, we provide detailed instructions on the use of endoscopic instrumentation to obtain biopsies, and the topical and intramucosal application of different components of interest (e.g., drug candidates or tumor cells). Finally, we demonstrate the use of murine fluorescence endoscopy, which employs sophisticated molecular imaging techniques, in the setting of colorectal tumors.

Access restricted. Please log in or start a trial to view this content.

Protocol

All animal experiments were approved by the Landesamt für Natur, Umwelt und Verbraucherschutz (LANUV) according to German Animal Protection Law.

1. Materials and Experimental Setup

  1. Animal care
    1. Use female or male mice of any strain weighing 20 to 25 g and house them according to local animal care legislation.
    2. Feed mice with special chow for rodents and apply alfalfa-free chow at least three days prior to fluorescence examinations to minimize endoluminal auto-fluorescence.
    3. Provide autoclaved drinking water ad libitum.
  2. Induction of acute DSS-induced colitis
    1. Prepare a 3% (w/v) dextran sulfate sodium (DSS, molecular weight: 36,000–50,000 Da) solution by dissolving 3 g of DSS in 100 ml autoclaved water. Offer this solution as the exclusive drinking water to mice ad libitum and calculate 5 ml of DSS-solution per mouse/day. Feed control mice with autoclaved water without DSS ad libitum9.
  3. Induction of colorectal cancer
    1. Dissolve mutagenic azoxymethane (AOM) (CAUTION! May cause cancer and genetic damage!) in sterile isotonic saline to obtain a final concentration of 1 mg/ml. Apply a single dose of 10 mg AOM per kg bodyweight intra-peritoneally using a 1 ml syringe (30 G)10.
    2. Challenge mice (excluding control mice) with repetitive cycles of 3% (w/v) DSS from day 0 to 7, day 14 to 21, day 28 to 35 and day 42 to 49 to induce inflammatory driven colorectal cancerogenesis. Feed mice with autoclaved water only in between these challenges (see Figure 4A for a detailed time schedule). Feed control mice with autoclaved water throughout the experiment.
  4. Preparation of fluorescence endoscopy (FE)
    1. Use Fluorescein-Isothiocyanat (FITC) - dextran (molecular weight 70,000 Da; FITC:Glucose = 1:250) for detection of colonic adenoma by visual enhancement of dysplasia associated vascular pattern.
    2. Administer 60 mg FITC-conjugated dextran diluted in 100 µl PBS intravenously 5 min before fluorescence endoscopic examination.
  5. Anesthesia
    1. Provide continuous isoflurane supply for anesthesia (1.5 L O2/min; 1.5–2 vol% isoflurane [2-chloro-2-(difluoromethoxy)-1,1,1-trifluoro-ethane]). Use special veterinary anesthesia equipment with a facemask to tightly control anesthesia.
  6. Preparation of enema
    1. Instill 2 ml of fluid enema (contents: disodium hydrogenphosphate 1.5% (w/v) and sodium dihydrogenphosphate 11% (w/v)) into the colon if significant fecal loading is suspected that may obscure the view.

2. Technical Equipment

  1. Use a veterinary endoscopic workstation that is developed and approved for the use of small animal endoscopy. Connect the workstation to a camera unit, a xenon light source, an air pump and to a conventional PC monitor for white light endoscopy. Then connect the camera and the miniature rigid telescope (1.9 mm outer diameter, 10 cm length; Figure 5).
  2. Use endoscope sheath with working channel (Figure 5D) for the application of biopsy forceps or injection tube. Use the sheath without working channel for diagnostic colonoscopy.
  3. Configure the settings of the light source for fluorescence endoscopy to excite used tracers (e.g., 490 nm for FITC-conjugated dextran). Additionally, integrate an appropriate bandpass filter between the telescope and the camera (e.g., 525 nm for FITC-conjugated dextran).
  4. Insert flexible biopsy forceps (3 Charr., 28 cm) through the working channel of the endoscope to obtain biopsies.
  5. Introduce flexible injection tube (0.96 mm) through the working channel for topical, intramucosal or endoluminal administration of diagnostic or therapeutic agents.
  6. Use a heatable examination table with a temperature of 42 °C. This prevents mice becoming hypothermic during the examination.

3. Anesthesia of Animals

  1. Place mouse in a small but leakproof box and administer isoflurane (100% (v/v), 5 vol%, 3 L/min). Wait until the mouse loses consciousness.
  2. Transfer the mouse onto the examination table for endoscopy. Continue isoflurane inhalation via face mask with a dose 100% v/v, 1.5 vol%, 1.5 L/min. Always apply eye ointment to prevent eye dryness while under anesthesia.
  3. Evaluate efficacy of anesthesia by checking the reflexes. Check the ‘turn around reflex’: if sufficiently anaesthetized, a mouse laying on its back should not turn around. Check the ‘toes reflex’: when anesthesia is adequate, soft pinching in between the animal’s toes should not lead to withdrawal of leg (stage of surgical tolerance).

4. Colonoscopy

  1. Lay anesthetized mouse prone /on its back on the examination table.
  2. Administer 2 ml of enema via buttoned cannula into the colon if significant fecal loading is suspected that may obscure the view. Wait for mice to defecate after administering the enema. Insert the endoscope very carefully to avoid perforation.
  3. Open both valves of the sheath with one of them being connected to the air pump. Seal the other valve with your index finger to dispense air. Inflate colon with air, slowly and carefully, especially in case of biopsy or injection.
  4. Advance endoscope only as far as the right colonic flexure to avoid perforation (4–5 cm from anus).
  5. Diagnostic colonoscopy
    1. Examine the mucosa for inflammatory or malignant alterations while pulling back the endoscope. Pull back slowly to assess the whole circumference of the bowel. Assess intraluminal pathologies using appropriate established scoring systems as required.
    2. To warrant identical endoscopic position for image acquisition during repetitive visualizations of wound areas, note the distance between the murine anus and the mucosal lesion. Moreover, use the tip of the biopsy forceps as a spacer to achieve identical distance between the endoscope and the wound area during image acquisition. The wound size is related to the size of the endoscope sheath, which comprises 3 mm.
      NOTE: Place endoscope in identical position by optical comparison with photo documentation of previous examinations. Measure lesions in the same angle and distance at each follow up endoscopic examination.
  6. Biopsy procedure
    1. Take biopsies with the help of two investigators. Introduce the biopsy forceps carefully through the working channel until the tip of the forceps is visible on the monitor to the second investigator. Open and close forceps carefully to avoid perforation.
    2. Move forceps to the site of pathology.
  7. Injection procedure
    1. Perform injection procedure with the help of two investigators. Pre-fill flexible injection tube (0.96 mm) completely with the agent to be administered. Push tube through the working channel until the cannula (30 G) is visible on the monitor to the second investigator. Prepare the fine syringe and gently administer the requested amount of diagnostic or therapeutic agent. Injection volumes should be 50 µl maximum.
    2. Insert the needle into the submocosa at an angle of 15–30 degrees. Face the bevel in direction of the mucosa. The mucosa shows a characteristic lifting sign after successful injection.
  8. Fluorescence endoscopy (FE)
    1. Administer 60 mg FITC-conjugated dextran diluted in 100 µl PBS intravenously prior to fluorescence endoscopic examination.
    2. Check the optimal time point between injection of your fluorescent labeled tracer and the imaging procedure which is dependent on tracer pharmacology. Configure settings of bandpass filter system in accordance to excitation and emission wavelength of the tracer used. Perform fluorescence endoscopy for non-specific blood volume tracers (e.g., FITC) immediately after intravenous injection of the fluorescent dye to assess the vascular pattern of the mucosal surface.
    3. Consider imaging several hours after tracer application in case of targeted tracers or ‘smart probes’ to provide a better target to background-ratio.
    4. Perform photo- and video-documentation of the results.

5. Post-colonoscopy

  1. Separate the mouse in a vacant cage and lay it on a paper towel to protect the mouse from aspirating the litter. Warm the mouse with a redlight lamp to prevent hypothermia. Observe the mouse and do not leave unattended until it has regained sufficient consciousness to maintain sternal recumbency. Once completely conscious, place the mouse back to its respective cage.
  2. At the end of experiment, place mouse in a small but leakproof box and administer CO2 (100% (v/v), 100 vol%, 3 L/min). Wait until the mouse loses complete consciousness and stops breathing. Dispatch mouse by neck fracture. Perform abdominal laparotomy and explant the colon. Open the colon longitudinally and wash it for further histological or molecular evaluation.

Access restricted. Please log in or start a trial to view this content.

Results

In vivo monitoring of intestinal wound healing
During routine endoscopy, mucosal wounds were induced mechanically by miniature biopsy forceps with a diameter of 3 French (equals 1 mm; Figure 1A). Subsequently, wound healing was monitored by daily endoscopic examinations and quantified by measurement of the residual wound area using image editing software, e.g., ImageJ (Figure 1B). The individual wound closure over time is expressed ...

Access restricted. Please log in or start a trial to view this content.

Discussion

Epithelial wound healing is an ongoing process. Continuous physiological exfoliation of surface cells within the gastrointestinal mucosa occurs requiring frequent regeneration of epithelial cells 16. Consequently, impaired wound healing has an immense impact on several diseases including gastrointestinal ulcers and 17 anastomotic leakage 18. Evaluation of molecular background as well as potential drug candidates to stimulate epithelial healing may only be incompletely performed in cell cu...

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

We thank Sonja Dufentester and Elke Weber for expert technical assistance. We thank Faekah Gohar for proofreading the manuscript and Stefan Brückner for medical informatics support. This work was supported by an interdisciplinary grant from the Else-Kröner-Fresenius-Stiftung (2012_A94). D. Bettenworth was supported by a research fellowship from the Faculty of Medicine, Westfälische Wilhelms-Universität Münster. M. Brückner was supported by a “Gerok” rotational position of the Deutsche Forschungsgemeinschaft (DFG SFB1009B8). We thank Heike Blum for illustration of the mouse cartoon.

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Reagents
Alfalfa-free dietHarlan Laboritories, Madison, USA2014
Azoxymethane (AOM)Sigma-Aldrich, Deisenhofen, GermanyA5486
Bepanthen eye ointmentBayer, Leverkusen, Germany80469764
Dextran sulphate sodium (DSS)TdB Consulatancy, Uppsala, SwedenDB001
EosinSigma-Aldrich, Deisenhofen, GermanyE 4382
Ethylenediaminetetraacetic acid (EDTA)Sigma-Aldrich, Deisenhofen, GermanyE 9884
Falcon Tube 50 mlBD Biosciences, Erembodegem, Belgium352070
Florene 100 V/VAbbott, Wiesbaden, GermanyB506
HaematoxylinSigma-Aldrich, Deisenhofen, GermanyHHS32-1L
Isopentane (2-Methylbutane)Sigma-Aldrich, Deisenhofen, GermanyM32631-1L
Methylene blueMerck, Darmstadt, Germany1159430025
O.C.T. Tissue Tek compound                                 Sakura, Zoeterwonde, Netherlands4583
Omnican F - canulaBraun, Melsungen, Germany9161502
Phosphate buffered saline, PBSLonza, Verviers, Belgium4629
Sodium Chloride 0.9%Braun, Melsungen, Germany5/12211095/0411
Standard dietAltromin, Lage, Germany1320
Tissue-Tek CryomoldSakura, Leiden, Netherlands4566
Vitro – Clud                                                               R. Langenbrinck, Teningen, Germany04-0002 
Equipment
AIDA ControlKarl Storz - Endoskope, Tuttlingen, Germany20 096020
Bandpass filterSemrock, Rochester, USAHC 716/40
Bandpass filterSemrock, Rochester, USAHC 809/81
Biopsy Forceps, 3 Fr., 28 cmKarl Storz - Endoskope, Tuttlingen, Germany61071ZJ
Dell MonitorDell, Frankfurt am Main, GermanyU2412Mb
Examination Sheath, 9 Fr.Karl Storz - Endoskope, Tuttlingen, Germany61029D
Examination Sheath, 9 Fr.Karl Storz - Endoskope, Tuttlingen, Germany61029C
Fiber Optic Light Cable, 3.5 mmKarl Storz - Endoskope, Tuttlingen, Germany69495NL
Fluorescein Blue Filter SystemKarl Storz - Endoskope, Tuttlingen, Germany20100032
Fluorescein Barrier FilterKarl Storz - Endoskope, Tuttlingen, Germany20100033
Foot switchKarl Storz - Endoskope, Tuttlingen, Germany20010430
HOPKINS Telescope, 1.9 mm, Length 10 cmKarl Storz - Endoskope, Tuttlingen, Germany1830231
SCB D-light P Karl Storz - Endoskope, Tuttlingen, Germany20 133720
SCB tricam SL IIKarl Storz - Endoskope, Tuttlingen, Germany20 2230 20
Tubing set instruments VETPUMP IIKarl Storz - Endoskope, Tuttlingen, Germany69811
Tricam PDD PALKarl Storz - Endoskope, Tuttlingen, Germany20221037
UniVet PortaGroppler Medizintechnik, Deggendorf, GermanyBKGM 0451
Vetpump 2Karl Storz - Endoskope, Tuttlingen, Germany69321620

References

  1. Bettenworth, D., et al. Translational 18F-FDG PET/CT imaging to monitor lesion activity in intestinal inflammation. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 54, 748-755 (2013).
  2. Lewis, J. S., Achilefu, S., Garbow, J. R., Laforest, R., Welch, M. J. Small animal imaging. current technology and perspectives for oncological imaging. European journal of cancer. 38, 2173-2188 (2002).
  3. Huang, E. H., et al. Colonoscopy in mice. Surgical endoscopy. 16, 22-24 (2002).
  4. Becker, C., et al. In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy. Gut. 54, 950-954 (2005).
  5. Becker, C., Fantini, M. C., Neurath, M. F. High resolution colonoscopy in live mice. Nature protocols. 1, 2900-2904 (2006).
  6. Neurath, M. F., et al. Assessment of tumor development and wound healing using endoscopic techniques in mice. Gastroenterology. 139, 1837-1843 (2010).
  7. Pickert, G., et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. The Journal of experimental medicine. 206, 1465-1472 (2009).
  8. Shapira, Y., et al. Utilization of murine laparoscopy for continuous in-vivo assessment of the liver in multiple disease models. Plos one. 4, e4776(2009).
  9. Wirtz, S., Neufert, C., Weigmann, B., Neurath, M. F. Chemically induced mouse models of intestinal inflammation. Nature protocols. 2, 541-546 (2007).
  10. Neufert, C., Becker, C., Neurath, M. F. An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Nature protocols. 2, 1998-2004 (2007).
  11. Dieleman, L. A., et al. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clinical and experimental immunology. 114, 385-391 (1998).
  12. Gao, Y., et al. Colitis-accelerated colorectal cancer and metabolic dysregulation in a mouse model. Carcinogenesis. 34, 1861-1869 (2013).
  13. Foersch, S., Neufert, C., Neurath, M. F., Waldner, M. J. Endomicroscopic Imaging of COX-2 Activity in Murine Sporadic and Colitis-Associated Colorectal Cancer. Diagnostic and therapeutic endoscopy. 2013, 250641(2013).
  14. Bremer, C., Ntziachristos, V., Weissleder, R. Optical-based molecular imaging: contrast agents and potential medical applications. European radiology. 13, 231-243 (2003).
  15. Keller, R., Winde, G., Terpe, H. J., Foerster, E. C., Domschke, W. Fluorescence endoscopy using a fluorescein-labeled monoclonal antibody against carcinoembryonic antigen in patients with colorectal carcinoma and adenoma. Endoscopy. 34, 801-807 (2002).
  16. Jones, M. K., Tomikawa, M., Mohajer, B., Tarnawski, A. S. Gastrointestinal mucosal regeneration: role of growth factors. Frontiers in bioscience : a journal and virtual library. 4, 303-309 (1999).
  17. Mertz, H. R., Walsh, J. H. Peptic ulcer pathophysiology. The Medical clinics of North America. 75, 799-814 (1991).
  18. Pantelis, D., et al. The effect of sealing with a fixed combination of collagen matrix-bound coagulation factors on the healing of colonic anastomoses in experimental high-risk mice models. Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie. 395, 1039-1048 (2010).
  19. Burk, R. R. A factor from a transformed cell line that affects cell migration. Proceedings of the National Academy of Sciences of the United States of America. 70, 369-372 (1973).
  20. Msaki, A., et al. The role of RelA (p65) threonine 505 phosphorylation in the regulation of cell growth, survival, and migration. Molecular biology of the cell. 22, 3032-3040 (2011).
  21. Zigmond, E., et al. Utilization of murine colonoscopy for orthotopic implantation of colorectal cancer. PloS one. 6, e28858(2011).
  22. Foersch, S., et al. Molecular imaging of VEGF in gastrointestinal cancer in vivo using confocal laser endomicroscopy. Gut. 59, 1046-1055 (2010).
  23. Mitsunaga, M., et al. Fluorescence endoscopic detection of murine colitis-associated colon cancer by topically applied enzymatically rapid-activatable probe. Gut. 62, 1179-1186 (2013).

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

In Vivo ImagingColitis ModelFluorescence EndoscopyMucosal Wound HealingIntestinal InflammationColorectal CancerEndoscopic BiopsyDSS TreatmentFluorescent Tracer

Related Articles